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ABSTRACT 
Amlodipine is a long-acting calcium channel blocker used in the treatment of hypertension and angina. 
In adult man, the treatment regimen is 5 or 10 mg daily. This study evaluated the effects of prolonged 
oral administration of Amlodipine Besylate on the morphology of bone marrow in adult male Wistar 
rats. Sixteen rats (140 - 190 g) comprising of four groups were employed in the study. Rats of Control 
Group I received physiological saline orally while rats of Experimental Groups II - IV received oral 
administrations of 5, 10 and 15 mg/kg bodyweight of Amlodipine Besylate respectively for nine weeks. 
Histo-pathological examinations of the bone marrow showed normal cytoarchitecture of erythrocytes 
and leukocytes in rats of Control Group I. However, dose-dependent degeneration and lyses of 
erythrocytes and leukocytes were observed in amlodipine-treated rats. In conclusion, impaired 
morphology of the bone marrow were observed in amlodipine-treated adult male Wistar rats 
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INTRODUCTION 
Hypertension is a global health concern which 
affects all ethnic groups, sexes and different 
age groups; though it is more prevalent in the 
adults. It affects 20 percent of people living in 
the world, a third of which is unaware of their 
condition. (Tripathy, 2003; Nicholas et al., 
2006; John and Arthur, 2011). Hypertension is 
usually treated with calcium channel blockers. 
(Tripathy, 2003). Amlodipine Besylate is a 
calcium ion antagonist which inhibits trans-
membrane influx of calcium ion into cardiac 
and vascular smooth muscles (Tripathy, 2003; 
Nicholas et al., 2006; John and Arthur, 2011).  
Calcium ions have ubiquitous presence in 
somatic and germ cells (Latif et al., 2008; Latif 
et al., 2009). Calcium ions are, therefore, of 
relevance in many biological processes such as 
bone formation, haemopoiesis, blood 
coagulation and co-factor for enzymes 
(Tripathy, 2003; John and Arthur, 2011) and 
signal transduction pathways where it is used 
as first and second messengers (Carafoli et al., 
2001; Bouschet and Henley, 2005) Amlodipine 
Besylate as a calcium ion antagonist will 
possibly interfere with the processes involved 
in bone formation and hematopoiesis. It is, 
therefore, relevant to evaluate the possible 
effects of Amlodipine Besylate on the 
morphology of bone marrow. Following 
thorough literature review, we are not aware 
of any study that examined the effects of 
Amlodipine Besylate administrations on the 
morphology of bone marrow of rats. This study 
evaluated the effects of prolonged oral 
administrations of Amlodipine Besylate on the 





MATERIALS AND METHODS 
Ethical Approval 
Ethical approval was sought and received from 
the Department of Anatomy of the University 
of Ilorin, Ilorin, Kwara State, Nigeria. The 
protocols for the use of animals in scientific 
Submitted 7th June 2016, revised on 7th September 2016. Published online 12th January 2017. To cite: AKINLOLU AA, 
GHAZALI OK, AYANTUNJI LB, OMOTOSO GO. Amlodipine Besylate impairs the morphology and functions of the bone 
marrow in adult male wistar rats. Anatomy Journal of Africa. 2017. Vol 6 (1): 867 -872. 
867 





research were strictly adhered to in compliance 
with World Health Organization’s provisions.  
Animal Care and Feeding 
Sixteen adult male Wistar rats weighing 140 - 
190 g obtained from the colony breed of the 
Animal House of the Department of Veterinary 
Physiology, University of Ibadan, Oyo State, 
Nigeria were employed in the study. Male rats 
were selected for the study to eliminate the 
possible effects of sex hormones such as 
Oestrogen, Follicle Stimulating Hormone and 
Luteinizing Hormone on the actions of 
Amlodipine Besylate in female rats. The male 
rats used for the study were housed in 
individual cages in a well ventilated and 
fumigated room with ambient temperature and 
good lighting. All rats were fed with standard 
pellet diet (Bendel Feeds Limited, Nigeria) and 
received water ad libitum. The rats were 
acclimatized for seven days before the start of 
experimental procedures. The weight of each 
rat was measured and computed daily. 
Furthermore, each rat was examined daily for 
possible behavioural and gross morphological 
or physical changes. 
 
Administrations of Drugs 
Rats of Control Group I (comprising of four 
rats) received physiological saline daily for nine 
weeks. In an adult 70 kg Man, the treatment 
regimen of Amlodipine Besylate for the 
treatment of hypertension or angina is 5 or 10 
mg daily. 5 mg Amlodipine Besylate (Norvasc, 
Pfizer, New Zealand) was dissolved in 333 
milliliters (ml) of Normal Saline effectively 
without any residue. Therefore, rats of 
Experimental Groups II – IV (each comprising 
of four rats) received daily corresponding oral 
administration of 5, 10 and 15 mg/kg 
Bodyweight of Amlodipine Besylate 
respectively for 56 - 65 days. Oral 
administration of drugs was done with the use 
of a 5 ml syringe and a flexible feeding tube 
long enough to reach the stomach through the 
oesophagus. 
The average weight of rats employed in the 
study was measured as 165 g. In an adult 70 
kg Man, the treatment regimen of Amlodipine 
Besylate is 5 or 10 mg daily.  Therefore, to 
determine the amounts of Amlodipine Besylate 
to be administered to each rat, the 
corresponding dosage (X mg) for a 165 g rat 
was calculated as follows:   X mg = (165 g × 
5 mg)/70,000 g = 0.012 mg of Amlodipine 
Besylate.  
If 5 mg Amlodipine Besylate was 
dissolved in 333 ml of Normal Saline solution, 
the volume (X ml) of the Amlodipine 
Besylate/Normal Saline solution that would 
contain 0.014 mg of Amlodipine Besylate was 
determined as follows: 
X ml = (0.012 mg × 333 ml)/5 mg = 3.996 
ml/5 = 0.80 ml (approximately 1 ml) of 
Amlodipine Besylate/Normal Saline solution.  
The rats were divided into the following 
groups: 
Group I: Control (4 ml saline, oral) 
Group II: Treated (5 mg/kg b.w. or 1 ml 
Amlodipine Besylate/Normal Saline Solution, 
oral) 
Group III: Treated (10 mg/kg b.w. or 2 ml 
Amlodipine Besylate/Normal Saline Solution, 
oral) 
Group IV: Treated (15 mg/kg b.w. or 3 ml 
Amlodipine Besylate/Normal Saline Solution, 
oral) 
Volumes of drugs solutions that were 
more than 2 ml were given twice daily to rats 
of Groups I and IV for eased ingestion. This 
was in consideration of the maximum 3.4 ml 
volume capacity of the stomach of adult rats 
(McConnell et al., 2008).  
 
Histological Preparations of the Bone 
Marrow for Giemsa Staining Technique 
At the end of experimental procedure, each rat 
was sacrificed by cervical dislocation. The 
lower limb was dissected; and the femur was 
removed and fixed in 10% formal saline of at 
least five times its volume. Bone marrow 
samples were aspirated from the femur. The 
microscope slides and spreader were cleaned 
thoroughly and ensured to be grease free. A 
drop of bone marrow aspirate was placed on 
each slide (at about 1cm from one edge of the 
slide) and the spreader was adjusted at an 
angle of about 45° to the slide. The spreader 
was drawn backward and forward with firm 
and smooth pressure. The smear was air-dried 
and the slide properly labeled.  
 
Microscopic slides were placed on the staining 
rack, covered and fixed with methanol for five 
minutes. The slides were flooded with May-





Grunwald solution and stained for fifteen (15) 
minutes. The stain was tipped off and slides 
flooded with Giemsa stain for 15 minutes. The 
stain was washed off under running water and 
the slides placed in the drying racks to air-dry.  
Slides were examined under the microscope 
using X 400 and oil immersion objective lens. 
(Lewis et al., 2003).  
 
Histological Preparations of the Bone 
Marrow for Haematoxylin and Eosin 
Staining Techniques 
The microscope slides and spreader were 
cleaned thoroughly and ensured to be grease 
free. A drop of bone marrow aspirate was 
placed on each slide (at about 1 cm from one 
edge of the slide) and the spreader was 
adjusted in such a way that it totally covered 
the slide and the bone marrow aspirate. The 
spreader was then drawn backward and 
forward with firm and smooth pressure. The 
smear was air-dried and the slide properly 
labeled. Microscopic slides were placed on the 
staining rack, stained with Haematoxylin, 
differentiated in 1% alcohol for twenty minutes 
and counter stained in eosin for three minutes. 
The stains were washed off in running water 






Histological Evaluations: Giemsa and 
Heamatoxylin and Eosin Staining 
Techniques 
Histological evaluations showed that rats of 
Control Group I had normal cytoarchitecture of 
erythrocytes and leucocytes. However, dose-
dependent degeneration and lyses of 
erythrocytes and leucocytes were observed in 
rats of Experimental Groups II – IV treated 
with 5, 10 and 15 mg/kg bodyweight of 























Figure 1a: Photomicrograph sample of the bone marrow 
of rats of Group I which received physiological saline, 
showing multifoci and normal cytoarchitecture of 
erythrocytes and leucocytes. Giemsa X 400. 
	
Figure 1b:   Photomicrograph sample of the bone marrow 
of rats of Group II which  received 5 mg/kg bodyweight of 
Amlodipine Besylate, showing mild degeneration and lyses 
of erythrocytes and leucocytes. Giemsa X 400. 
	
















































Figure 1c:  Photomicrograph sample of the bone marrow of 
rats of Group III which received 10 mg/kg bodyweight of 
Amlodipine Besylate, showing marked degeneration and 
lyses of erythrocytes and leucocytes. Giemsa X 400. 
	
Figure 1d:   Photomicrograph sample of the bone 
marrow of rats of Group IV which received  15 mg/kg 
bodyweight of Amlodipine Besylate, showing foci 
adipocytes, marked degeneration and lyses of 
erythrocytes and  leucocytes. Giemsa X 400. 
	
Figure 2a: Photomicrograph sample of the bone 
marrow of rats of Group I which received physiological 
saline, showing normal nucleated erythrocytes and 
leucocytes. Haematoxylin and Eosin X 400. 
	
Figure 2b:  Photomicrograph sample of the bone 
marrow of rats of Group II which received  5 mg/kg  
bodyweight of Amlodipine Besylate, showing 
degeneration and lyses of erythrocytes and leucocytes. 
Haematoxylin and Eosin X 400. 
	






















Histological evaluations showed that rats of 
Control Group I had normal cytoarchitecture of 
erythrocytes and leucocytes. However, dose-
dependent degeneration and lyses of 
erythrocytes and leucocytes were observed in 
rats of Experimental Groups II – IV treated 
with 5, 10 and 15 mg/kg bodyweight of 
Amlodipine Besylate (Figures 1a-d and 2a-d). 
The observed anomalies of the morphology of 
bone marrow implied that Amlodipine Besylate 
as a calcium channels blocker negatively 
interacted with the functions of calcium ions as 
a major component of bones and regulator of 
haemopoiesis.  
Literature review observed paucity of 
studies which evaluated the effects of 
Amlodipine Besylate on bone marrow of rats. 
However, the observations of this study are in 
agreement with earlier observations of adverse 
effects of Amlodipine Besylate on bone 
meatabolism in rats. Amlodipine Besylate 
administration was reported to have resulted in 
20 - 30% decrease in bone volume fraction in 
the healing process of alveoli of rats following 
tooth extraction (Teofilo et al., 2001) and 
unlike Clinidipine did not prevent or ameliorate 
osteoporosis in ovariectomized hypertensive 
rats. (Shimizu et al., 2012). 0.04 mg/rat/day 
Amlodipine Besylate resulted in slight delay in 
the chronology of the repair process, 
significant decrease of newly formed bone 
volume and alkaline phosphatase levels in the 
repairing process of surgical defect in the 
mandibular ramus of rats. (Moraes et al., 
2011). Similarly, 0.3 mg/100 g bodyweight of 
Amlodipine Besylate administration resulted in 
increased expression of bone morphogenetic 
protein-2 (BMP-2) and decreased bone 
turnover rate in male wistar rats. (Gradosova 
et al., 2011). 
 The observations of this study are, 
however, in disagreement with earlier studies 
which observed that 1 and 3 mg/kg 
bodyweight of Amlodipine Besylate resulted in 
significant increase in calcium and phosphorus 
concentrations in the femurs of ovariectomised 
rats with a beneficial effect on bone 
metabolism (Halici et al., 2008); and mitigated 
the effects of orchidectomy implying that it 
could prevent osteoporosis in rats. (Gradosova 
et al., 2012).  
In conclusion, dose-dependent 
impaired morphology of the bone marrow were 
observed in adult wistar rats treated with 5, 10 
and 15 mg/kg bodyweight of Amlodipine 
Besylate. This implied that Amlodipine Besylate 
should only be used based on medical 
prescription and should not be abused. Uses of 
Figure 2c: Photomicrograph sample of the bone marrow of 
rats of Group III which received  10 mg/kg bodyweight of 
Amlodipine Besylate, showing severe degeneration and 
lyses of erythrocytes and leucocytes. Haematoxylin and 
Eosin X 400. 
	
Figure 2d:   Photomicrograph sample of the bone 
marrow of rats of Group IV which received  15 mg/kg 
bodyweight of Amlodipine Besylate, showing severe 
degeneration and lyses of erythrocytes and leucocytes. 
Haematoxylin and Eosin X 400. 
	





Amlodipine Besylate against medical 
prescriptions to achieve assumed accelerated 
relief of hypertension by drug abusers could 
possibly result in adverse effects on the 
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